For those expecting the price to explode upward immediately after Adcom, I would caution to temper expectations. You need not look any further that the recent AIMT adcom. Immediately after the positive vote the message boards were full of posters exclaiming price would shoot from $23 to $40. The stock traded down the next day.
AIMT is going nowhere w/o sales. It has no label or availability or even much clarity. The survey of docs was a positive surprise that came up out of the dark, but is/was limited in impact. AMRN is has been on the shelf for years and has a healthy off label script presence. It still awaits the label and better coverage, but I see a ramp from the get go as a possibility.
And JL; I have no sense of humor. I'm not the Joker. Hell, I'm not even the Riddler. Though I do share his restrained demeanor.